Live News EQUITY FLASH L impact Nov 03, 2026, 02:44 PM UTC BioVal Analysis Covers SynAct’s Resomelagon Across Three Indications A BioVal analysis covers SynAct’s resomelagon across three indications. SquawkNews Desk